Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
K
K M, Preethushree
Pooja Bhagavat Memorial Mahajana Education Centre
(
T1030-01-05
)
GCMS Analysis of Bioactive Compounds of Extracted Growth Hormone Concentration (Auxin) and Antimicrobial Activity of
Pentas
lanceolata and
Chrysanthemum
Morifolium: An Ornamental Flowering Plants
Preethushree K M
Favorite
K.C., Remant
University of Alberta
(
M1430-01-04
)
Implementing siRNA Therapy Targeted at MLL-AF4 in Acute Lymphoblastic Leukemia
Remant K.C.
Favorite
Kadavil, Hana
Qatar University
(
M1430-01-02
)
Revolutionizing Ocular Drug Delivery: Prolonged Sunitinib Release from Elastomeric Biodegradable Injectable Tiny Implants for Treatment of Diabetic Retinopathy
Hana Kadavil
Favorite
Kalpana, Marjina Akter
University of Nebraska Medical Center
(
T1030-01-04
)
Development of Polymer-Based miRNA Delivery System for CXCR4 Inhibition and miR155 Inhibition in Target Cells in the Liver to Treat Alcohol-Associated Liver Disease
Marjina Akter Kalpana
Favorite
Kandalam, Umadevi
Woody L. Hunt School of Dental Medicine
(
T0930-02-06
)
Co-culture of Pre-programmed Angiogenic and Osteogenic Gingival Stem Cells Enhances Osteogenesis
Umadevi Kandalam
Favorite
Kandel, Sagar
Southeast Missouri State University
(
M0930-01-03
)
Antiproliferative Effects of Low Level Light-Low Dose Magnetic Nanoparticle Exposure on Human Umbilical Vein Endothelial Cells
Sagar Kandel
Favorite
Kang, David
Halozyme Therapeutics, Inc.
(
T0930-01-05
)
Preclinical Subcutaneous Injectability and Local Tolerability of an Antibody-Drug Conjugate Delivered with Recombinant Human Hyaluronidase PH20 Using a Handheld High-Volume Auto-Injector
David Kang
Favorite
Kang, Dong Wook
College of Pharmacy, CHA University
(
T1330-02-08
)
First-in-Human Dose Optimization of Enavogliflozin Eye Drops via Population PBPK Modeling for Treatment of Diabetic Retinopathy
Dong Wook Kang
Favorite
Kaplan, Gilad
AstraZeneca
(
T1030-02-07
)
Viscosity Reduction of an IgG1 Antibody via Hydrogen-Deuterium Exchange Mass Spectrometry-Augmented Protein Engineering
Gilad Kaplan
Favorite
Kelly, Ryan
Genentech, Inc.
(
M1030-02-07
)
Pharmacokinetic/Pharmacodynamic Insights into VSIG4 Degrading Antibodies
Ryan Kelly
Favorite
Khera, Eshita
Novartis
(
T1230-02-08
)
Reverse Translational Modeling for Early Benchmarking of Clinically Active Doses from In Vitro Cell Killing and T-Cell Activation Data for BCMAxCD3 T-Cell Engagers
Eshita Khera
Favorite
Kim, Daniel
Boehringer Ingelheim
(
T1030-02-08
)
Systematic Optimization of ADA Assays for Complex Biologics: A Framework for Addressing Assay Challenges Across Modalities
Daniel Kim
Favorite
Kim, Do Hyeon
TriOar Inc.
(
M1230-02-06
)
Application of icIEF-UV/MS for Rapid Proteoform Characterization and Charge Variant Analysis of a Novel Antibody-Drug Conjugate in Drug Discovery
Do Hyeon Kim
Favorite
(
M1530-02-08
)
Charge Variant Profiling of Antibody-Drug Conjugate Containing Auristatins Using icIEF-UV-MS
Do Hyeon Kim
Favorite
Kim, Ju Hee
CHA University
(
T1330-02-08
)
First-in-Human Dose Optimization of Enavogliflozin Eye Drops via Population PBPK Modeling for Treatment of Diabetic Retinopathy
Ju Hee Kim
Favorite
Kim, Seoyeon
ChungNam National University
(
M0930-02-09
)
Comprehensive Pharmacokinetic Profiling of C004019: A PROTAC Targeting Tau Protein in Neurodegenerative Disorders
Seoyeon Kim
Favorite
(
M1430-02-07
)
Assessment of Antibody-Drug Conjugate Stability in Mouse Skin Homogenate Supernatant Using Liquid Chromatographic-Quadrupole Time-of-Flight Mass Spectrometric Method
Seoyeon Kim
Favorite
(
M1430-02-09
)
Application of Sequential Window Acquisition of all Theoretical Fragment Ion Spectra Mass Spectrometry (SWATH-MS) for Identification of Tetrapeptide Linker Cleavage Profile of Antibody Drug Conjugate
Seoyeon Kim
Favorite
(
M1530-02-07
)
Simultaneous Analysis of Antibody-Conjugated Drug(acDrug) and Total Antibody(tAb) for Antibody Drug Conjugate Using Dual Enzyme-Assisted Sample Preparation Followed by LC-MS
Seoyeon Kim
Favorite
Kindhart, Richard
Merck & Co., Inc.
(
T1430-02-09
)
Overcoming Selectivity Barriers of a Ligand Binding Assay
Richard Kindhart
Favorite
King, Lindsay
Pfizer Inc.
(
M1130-02-07
)
Embracing Singlicate Ligand Binding Biomarker Assays: A Case Study Comparing Duplicate vs Singlicate Analysis for the Determination of IL-6, IFN-gamma, and TNF-alpha in Human Sodium Heparin Plasma
Lindsay King
Favorite
Kirkpatrick, Stacy
University of Tennessee
(
M1430-01-03
)
Enhanced Membrane Composition for Lipid Nanoparticle Vascular Drug Delivery
Stacy Kirkpatrick
Favorite
(
T1430-01-04
)
Long-Term Storage of Targeted Lipid Nanoparticles for Vascular Gene Therapies
Stacy Kirkpatrick
Favorite
Kolomiyets, Anton
BioAgilytix
(
T1030-02-06
)
Qualification of the S-PLEX Neurology Panel 1 (GFAP, NfL and Tau) MSD Assay
Anton Kolomiyets
Favorite
Kolpek, Daniel
University of Kentucky
(
M0930-02-06
)
Investigations into the Effects of Protein Corona Formation on Novel Polymeric Nanoparticle Systems
Daniel Kolpek
Favorite
Konovalov, Andrey
Boehringer Ingelheim
(
T1030-02-08
)
Systematic Optimization of ADA Assays for Complex Biologics: A Framework for Addressing Assay Challenges Across Modalities
Andrey Konovalov
Favorite
Koobatian, Maxwell
Crinetics
(
T1430-01-02
)
Insights from Drug Development Experts: Surveying Challenges and Outcomes for Large-Volume Subcutaneous Oncology Drugs
Maxwell Koobatian
Favorite
Kopcho, Noah
Gyros Protein Technologies
(
M1330-02-08
)
Analysis of Pre-existing Anti-AAV Antibodies Using a Novel Nanoliter Total Antibody Assay: A Serotype-Independent Approach
Noah Kopcho
Favorite
(
T1430-02-06
)
Immunogenicity Assessment of Both Anti-Drug Antibodies in Experimental Animals: Complexed with Drug or in Free Form Using an Automated Workflow
Noah Kopcho
Favorite
Kotowski, Don
Merck & Co., Inc.
(
M1330-01-01
)
Utility of Small Angle X-Ray Scattering (SAXS) in Process Development, Characterization and Comparability of Lipid Nanoparticles, Liposomes and Fusion Proteins
Don Kotowski
Favorite
Kuebler, Sigrid
Yokogawa Fluid Imaging Technologies
(
T1030-01-01
)
Using Flow Imaging Microscopy to Meet Particulate Matter Standards for Biotherapeutics
Sigrid Kuebler
Favorite
Kumari, Neha
University of Nebraska Medical Center
(
T1030-01-04
)
Development of Polymer-Based miRNA Delivery System for CXCR4 Inhibition and miR155 Inhibition in Target Cells in the Liver to Treat Alcohol-Associated Liver Disease
Neha Kumari
Favorite
Kumar, Naveen
Surana College Autonomus
(
T1030-01-05
)
GCMS Analysis of Bioactive Compounds of Extracted Growth Hormone Concentration (Auxin) and Antimicrobial Activity of
Pentas
lanceolata and
Chrysanthemum
Morifolium: An Ornamental Flowering Plants
Naveen Kumar
Favorite
Kumar, Ramya
Colorado School of Mines
(
T0930-02-09
)
Polyplex Particle Size Alters Transgene Expression and Cell Viability in a Cell Type-Dependent Manner
Ramya Kumar
Favorite
